PD
CABA icon

Point72 (DIFC)’s Cabaletta Bio CABA Stock Holding History

Point72 (DIFC)’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,432
Closed -$3.7K – 1234
2025
Q2 		$3.7K Buy
+2,432
New +$3.79K ﹤0.01% 1403
2025
Q1 		– Sell
-11,755
Closed -$26.7K – 1697
2024
Q4 		$26.7K Buy
11,755
+4,768
+68% +$16.7K ﹤0.01% 1217
2024
Q3 		$33K Buy
+6,987
New +$40.4K ﹤0.01% 1153
2024
Q2 		– Sell
-33,973
Closed -$580K – 1496
2024
Q1 		$580K Buy
+33,973
New +$729K 0.02% 706

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Point72 (DIFC)'s CABA Position: Q3 2025 in Review

Point72 (DIFC) sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 2,432 shares — an estimated $3.7K sold.

Point72 (DIFC) first reported a position in CABA in Q1 2024 and held it in 4 quarters. The position peaked at $580K in Q1 2024. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • Point72 (DIFC) reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 2,432 Cabaletta Bio shares in Q3 2025, an estimated $3.7K.
  • Point72 (DIFC) first reported a position in Cabaletta Bio in Q1 2024 and held it in 4 quarters.
  • Point72 (DIFC)'s Cabaletta Bio position peaked at $580K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.